Health
‘This Is a Dangerous Virus’
When bird flu first struck dairy cattle a year ago, it seemed possible that it might affect a few isolated herds and disappear as quickly as it had appeared. Instead, the virus has infected more than 900 herds and dozens of people, killing one, and the outbreak shows no signs of abating.
A pandemic is not inevitable even now, more than a dozen experts said in interviews. But a series of developments over the past few weeks indicates that the possibility is no longer remote.
Toothless guidelines, inadequate testing and long delays in releasing data — echoes of the missteps during the Covid-19 pandemic — have squandered opportunities for containing the outbreak, the experts said.
In one example emblematic of the disarray, a few dairy herds in Idaho that were infected in the spring displayed mild symptoms for a second time in the late fall, The New York Times has learned. In mid-January, the Department of Agriculture said that no new infections in Idaho herds had been identified since October. But state officials publicly discussed milder cases in November.
That a second bout of infections would produce milder symptoms in cattle is unsurprising, experts said, and could be welcome news to farmers. But reinfections suggest that the virus, called H5N1, could circulate on farms indefinitely, creating opportunities for it to evolve into a more dangerous form — a “high-risk” scenario, said Louise Moncla, an evolutionary biologist at the University of Pennsylvania.
“You could easily end up with endemically circulating H5 in dairy herds without symptoms, obscuring rapid or easy detection,” Dr. Moncla said.
It’s impossible to predict whether the virus will evolve the ability to spread among people, let alone when, she and others said. But the worry is that if bird flu finds the right combination of genetic mutations, the outbreak could quickly escalate.
“I’m still not pack-my-bags-and-head-to-the-hills worried, but there’s been more signals over the past four to six weeks that this virus has the capacity” to set off a pandemic, said Richard Webby, an influenza expert at St. Jude Children’s Research Hospital.
Federal officials, too, have subtly altered their tone in discussing the outbreak, now emphasizing how quickly the situation might change.
For the general public, H5N1 is “a low risk, relative to the other risks they face today,” said Dr. Nirav Shah, principal deputy director of the Centers for Disease Control and Prevention. But “100 percent, that could change,” he said. “This is a dangerous virus.”
Health experts emphasize that there are precautions Americans can take: Do not touch sick or dead birds or other animals; get tested if you have flulike symptoms; do not consume raw milk or meat, or feed them to your pets.
If a larger outbreak were to erupt, the federal vaccine stockpile holds a few million doses, although that vaccine might first need updating to match the evolved form of the virus. In either case, officials would have to scramble to produce enough for the population.
The C.D.C. recommends treatment with the antiviral Tamiflu, but studies have shown that the drug does very little to ease illness.
Underlining concerns among many experts is that Robert F. Kennedy Jr., who would lead the federal health department if confirmed, was a vocal critic of Covid vaccines and has said the bird flu vaccines “appear to be dangerous.”
Even if the second Trump administration embraces vaccine development, as the first one did when Covid bore down, it’s unclear how many Americans would roll up their sleeves for the shots. Influenza typically affects children and older adults, and pandemic influenza has sometimes hit young adults the hardest. But the mistrust engendered during Covid-19 may make Americans eschew precautions, at least initially.
An evolving threat
Unlike the coronavirus, which caused havoc with its sudden arrival, influenza viruses typically start off in a specific animal species or in certain geographical regions.
When H5N1 emerged in East Asia nearly three decades ago, it mostly sickened birds. In the years that followed, it infected at least 940 people, nearly all of whom had close, sustained contact with infected birds; roughly half of those people died.
But since January 2022, when the virus was detected in wild aquatic birds in the United States, it has affected more than 136 million commercial, backyard and wild birds, helping to send egg prices soaring. It has also struck dozens of mammalian species, including cats both wild and domesticated, raccoons, bears and sea lions.
For at least a year, H5N1 has been infecting dairy cattle, which were not known to be susceptible to this type of influenza. In some cows, it has had lasting effects, reducing milk production and increasing the odds of spontaneous abortions.
And in 2024, the virus infected 67 Americans, compared with just one in the years before, in 2022. The sources of these infections are not all known; one person may have transmitted the virus to someone in their household.
Many of these developments are classic steps toward a pandemic, said Dr. James Lawler, a director at the University of Nebraska’s Global Center for Health Security. But, he noted, “where those were really supposed to trigger accelerated and amplified actions at the federal, state and local level, we’ve just kind of shrugged when each milestone has passed.”
Infections in dairy herds, which first emerged in Texas, appeared to be declining last summer. But in late August, California announced its first case. The state’s figures soon rose sharply, prompting Gov. Gavin Newsom to declare a public health emergency in December.
“That was sort of a flag to me, like, ‘OK, this hasn’t gone away,’” said Dr. Manisha Juthani, commissioner of the Connecticut Department of Public Health. “Over the last couple of months, it has felt like the tempo has increased,” she said.
Several other recent events have raised the level of alarm among experts. In early December, scientists reported that in a lab setting, a single mutation helped the virus infect human cells more efficiently.
And late last year two people, a 13-year-old Canadian girl and a Louisiana resident older than 65, became seriously ill; previously, most people infected with H5N1 had not experienced severe symptoms. The Louisiana patient, who had health conditions and cared for sick and dying birds, died in early January.
The girl was placed on life support because of organ failure, but eventually recovered. Scientists still do not know how she became infected; her only risk factor was obesity.
Both patients had contracted a new version of the virus that is distinct from the one in dairy cattle and is now widespread in birds. In both individuals, the virus gained mutations during the course of infection that might allow it to better infect people.
“We are clearly now getting novel viruses forming in the wild bird reservoir,” Dr. Moncla said. “It’s become challenging to keep a handle on all of the various threats.”
Some experts see it as particularly worrisome that the virus seems to be in food sources like raw milk and raw pet food. Domesticated cats have died in numerous states, prompting the recall of at least one brand of pet food and new federal guidelines on pet food quality.
“The raw-pet-food thing to me is, I think, quite alarming,” said Dr. Jeanne Marrazzo, director of the National Institute of Allergy and Infectious Diseases.
Pasteurization kills live virus, as does cooking meat at high temperatures. Still, neither procedure is perfect, Dr. Marrazzo noted: “There’s no way that you can police production and sterilization in a way that’s going to make sure 100 percent of the time that food supply is going to be safe.”
A flawed response
In the year since the outbreak began, federal officials have announced other measures to prevent or prepare for a pandemic. But each is deeply flawed, experts said.
The U.S. Department of Agriculture was slow to begin testing H5N1 vaccines for cows, leaving interested companies in limbo. Dr. Marrazzo said that the department had released genetic information from virus samples but had not said where or when they were collected — details that would help scientists track the virus’s evolution.
It is also unclear how many herds are reinfected or have been battling monthslong infections. In Idaho, some herds infected in the spring seemed to recover but showed milder symptoms again in November.
“From the data we have to date, we do not see evidence of new infections or reinfections in previously affected herds, but rather a lack of clearance of the original infection,” a spokesman for the U.S.D.A. said in an emailed response. But outside experts said that the trajectory of symptoms suggested a second round of illness.
The U.S.D.A.’s program to test bulk milk began in December — nearly a year after the outbreak began — and still does not include Idaho. Engaging private companies may help the program move faster.
Ginkgo Bioworks, a company that worked with federal agencies during the Covid pandemic, already assesses roughly half the nation’s commercial milk supply for bacteria, antibiotics and other substances.
Adding H5N1 to the list would be straightforward, so “why wouldn’t we just add assays into this infrastructure that we already have?” said Matt McKnight, a manager at the company’s biosecurity division.
Earlier this month, the Biden administration announced $306 million in new funding, about one-third of it for surveillance, testing and outreach to farmworkers.
But farmworkers in some places like the Texas Panhandle are still unaware of what bird flu is, how it spreads and why it should matter to them, said Bethany Alcauter, director of research and public health programs at the National Center for Farmworker Health.
As a result, she said, many workers still do not use protective gear, including in milk parlors where the virus is thought to spread.
Human testing has been voluntary, and infections have been missed. Few farmworkers have opted to be tested, out of fear of immigration officials or their own employers.
“If you don’t look for it, you won’t find it, right?,” said Dr. Deborah Birx, who served as White House Coronavirus Response Coordinator under President Trump. “This is not about lockdowns or restricting activity. It’s about protecting the individual American by empowering them with the information.”
Health
Marijuana compound may help prevent dementia when paired with common drug
NEWYou can now listen to Fox News articles!
As marijuana’s potential health benefits are under debate, new research has found that THC could have a powerful and positive effect on the brain.
Researchers at the University of Texas (UT) at San Antonio, Long School of Medicine, recently discovered that THC (tetrahydrocannabinol, the main psychoactive compound in marijuana) could prevent the development of Alzheimer’s disease – but only when paired with an anti-inflammatory drug called celecoxib.
Celecoxib is a selective COX-2 inhibitor that is commonly prescribed for arthritis and pain.
ALZHEIMER’S DECLINE COULD SLOW DRAMATICALLY WITH ONE SIMPLE DAILY HABIT, STUDY FINDS
While THC has previously been shown to have anti-inflammatory and neuroprotective properties, it’s also been linked to negative effects on the brain, particularly in learning and memory, according to a UT Health press release.
Combining THC with an anti-inflammatory drug, however, could provide the same benefits with fewer negative side effects.
THC could be powerful against cognitive decline when combined with an anti-inflammatory, a new study suggests. (iStock)
The study, which was published in the journal Aging and Disease, paired low-dose THC extract with celecoxib, which was administered to mice daily for 30 days.
The mice received the treatments before the development of memory symptoms to measure the impact on preventing or delaying Alzheimer’s.
CANCER MAY TRIGGER UNEXPECTED DEFENSE AGAINST ALZHEIMER’S DISEASE, RESEARCHERS SAY
The results showed improved cognition, learning and memory, as well as decreased markers of neuroinflammation and reduced Alzheimer’s-related brain pathology, the release stated.
Although THC alone had the same results, it also increased inflammatory signals, while the combination dosage did not.
The THC and celecoxib combo improved cognition, learning and memory, while also decreasing markers of neuroinflammation and reduced Alzheimer’s-related brain pathology. (iStock)
“What really mattered was behavior. If cognition is not improved, then the treatment doesn’t matter. And that’s where the combination clearly worked better than THC alone,” noted lead study author Chu Chen, Ph.D., professor in the Department of Cellular and Integrative Physiology.
Years of research led Chen to connect the dots on how THC can manipulate the brain and why it’s difficult to use safely for neurological conditions, according to UT Health.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“When THC is given, it unexpectedly increases COX-2 in the brain. That increase is closely associated with learning and memory impairment,” Chen said.
Both THC and celecoxib are FDA-approved for use in humans, which could provide a “real advantage” in moving along to clinical trials, according to UT Health.
“What really mattered was behavior. If cognition is not improved, then the treatment doesn’t matter.”
Future studies will investigate whether the drug combination can slow disease progression or reverse deficits after symptoms have appeared.
CLICK HERE FOR MORE HEALTH STORIES
“This work has taken many years. But now we’re at a point where basic neuroscience discoveries are pointing toward something that could realistically move into the clinic,” Chen said.
Dr. Paul Saphier, a neurosurgeon and founder of Coaxial Neurosurgical Specialists in New Jersey, called this research an “exciting breakthrough with a huge potential impact for patients and their families.”
“We know that the buildup of the plaques related to Alzheimer’s [beta-amyloid plaques] are the result of chronic inflammation.” (iStock)
“Neurocognitive deterioration has been linked to conditions that cause inflammation within the brain — prior brain bleeds, strokes, tumors and infections,” he told Fox News Digital. “We also know that the buildup of the plaques related to Alzheimer’s [beta-amyloid plaques] are the result of chronic inflammation.”
“So, it makes sense that this combination therapy [might] help limit the production of this amyloid and thereby reduce the progression of the disease.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Saphier said the drugs’ FDA approval status is “encouraging,” as it may “ultimately ease the availability for patients, if the trial proves successful.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“I look forward to the results of this trial, as well as any future trials that look at limiting the effects of chronic inflammation within the central nervous system.”
Health
Cancer may trigger unexpected defense against Alzheimer’s disease, researchers say
NEWYou can now listen to Fox News articles!
Puzzling cancer and Alzheimer’s link explored in new study: ‘SHORT QUOTE’
A new study may help clarify a long-observed link between cancer history and reduced Alzheimer’s risk.
The research, published in the journal Cell, used mouse models to explore how the biological changes associated with cancer may affect the progression of the most common dementia type.
The findings suggest that certain cancers release a protein called cystatin-C that can travel through the bloodstream and enter the brain, an area that many Alzheimer’s treatments have difficulty reaching.
ALZHEIMER’S RISK TIED TO HOW THE BODY HANDLES SUGAR AFTER EATING, STUDY FINDS
Cystatin-C binds to harmful amyloid protein clumps linked to Alzheimer’s and activates a protein called TREM2, which acts like an on-switch for the brain’s immune cells.
When activated, those cells begin clearing away existing amyloid plaques, a process that was associated with reduced plaque buildup and improved cognitive function, the study found.
New research suggests that cancer-related biological changes may help explain why a history of cancer is linked to lower Alzheimer’s risk. (iStock)
Dr. Bob Arnot, a Vermont-based internal medicine physician, told Fox News Digital that the findings help clarify a pattern doctors have observed for years.
“Scientists have long observed a puzzling statistical pattern known as ‘inverse comorbidity’ — people with a history of cancer are less likely to develop Alzheimer’s disease, and people with Alzheimer’s are less likely to develop cancer,” said Arnot, who was not involved in the study.
Cystatin-C sticks to harmful amyloid clumps and turns on brain immune cells, helping them clear plaques and improve brain function. (iStock)
The findings suggest that biological signals tied to certain cancers may slow or reverse key features of Alzheimer’s disease.
CLICK HERE FOR MORE LIFESTYLE STORIES
Arnot said the research is notable because it identifies a specific biological pathway that could be targeted for future Alzheimer’s treatments.
“This approach targets existing amyloid plaques, not just early prevention. That distinction could be critical for patients who already have established disease,” he said.
The results suggest that cancer-related biological signals may help slow or even reverse some core aspects of Alzheimer’s disease. (iStock)
Arnot cautioned that the findings do not mean cancer itself is protective.
“This study does not suggest that cancer is protective, desirable or a viable therapy,” he said. “Instead, it reveals that biological programs activated during cancer can inadvertently engage protective immune mechanisms in the brain.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The research suggests that future treatments could focus not just on slowing Alzheimer’s, but also on clearing harmful buildup in the brain, Arnot added.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The results were based on experiments in animal models, and further research is needed to determine whether the same effects occur in humans, the researchers noted.
Health
Measles exposure risk identified at major airport and theme park, health officials warn
NEWYou can now listen to Fox News articles!
Health officials are warning the public of potential measles exposure after an international traveler visited several high-traffic locations in Southern California, including Los Angeles International Airport (LAX) and the Disneyland Resort.
The traveler arrived Jan. 26 on Viva Aerobus Flight 518 at Tom Bradley International Terminal B, Gate 201A, according to a statement from the Los Angeles County Department of Public Health (LADPH).
The department stated that individuals who were in Terminal B between 10:45 p.m. Jan. 26 and 1 a.m. Jan. 27 may have been exposed.
MEASLES OUTBREAK REACHES A MAJOR SOUTH CAROLINA COLLEGE CAMPUS
Following the arrival, the individual traveled to Orange County. The Orange County Health Care Agency shared the following exposure windows for Jan. 28.
- Goofy’s Kitchen (Disneyland Hotel) between 10:30 a.m. and 1:30 p.m.
- Disneyland Park and Disney California Adventure from 12:30 p.m. until park closure
Goofy’s Kitchen in Disneyland Hotel was one site of potential measles exposure. (Photo by AaronP/Bauer-Griffin/GC Images)
A subsequent exposure was identified on Jan. 30 at a Dunkin’ Donuts in Woodland Hills, according to the LADPH.
“People who were at these locations during these times may be at risk of developing measles from seven to 21 days after exposure,” the Orange County Health Care Agency said in a statement.
CLICK HERE FOR MORE HEALTH STORIES
Health officials advise anyone who visited these locations during the specified windows to check their immunization status and monitor for symptoms for 21 days following exposure.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Public health departments in both Los Angeles and Orange County will continue to track potential exposure sites and notify individuals at high risk.
People should contact a healthcare provider by phone before visiting a clinic if symptoms develop to prevent further spread, experts recommend.
The infected passenger was an international traveler at Los Angeles International Airport (LAX). (KENA BETANCUR/AFP via Getty Images)
Fox News Digital reached out to county officials for a statement.
What to know about measles
Measles is a highly contagious viral disease. If one person is infected, up to 90% of nearby people who are not immune will also become infected, according to the Centers for Disease Control and Prevention.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“Measles doesn’t only affect people who travel internationally — everyone is at risk if they’re not protected,” said Dr. Anissa Davis, deputy county health officer for Long Beach, California. “The best way to protect yourself and your loved ones is to get vaccinated before exposure occurs.”
Visitors at Disneyland on the listed dates and times should exercise caution and limit contact with others, according to experts. (Getty Images)
Symptoms of measles typically include fever, cough, runny nose and red eyes, followed by a characteristic rash that begins on the face and spreads downward, per the CDC. An infected person is contagious for four days before and four days after the rash appears.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
As of Jan. 30, there have been 588 confirmed cases of measles in the U.S. so far in 2026, the agency reports. This follows a significant surge in 2025, which saw 2,267 cases — the highest annual count in more than three decades.
-
Indiana3 days ago13-year-old rider dies following incident at northwest Indiana BMX park
-
Massachusetts4 days agoTV star fisherman, crew all presumed dead after boat sinks off Massachusetts coast
-
Tennessee4 days agoUPDATE: Ohio woman charged in shooting death of West TN deputy
-
Pennsylvania1 week agoRare ‘avalanche’ blocks Pennsylvania road during major snowstorm
-
Movie Reviews1 week agoVikram Prabhu’s Sirai Telugu Dubbed OTT Movie Review and Rating
-
Indiana2 days ago13-year-old boy dies in BMX accident, officials, Steel Wheels BMX says
-
Culture1 week agoTry This Quiz on Oscar-Winning Adaptations of Popular Books
-
Politics6 days agoVirginia Democrats seek dozens of new tax hikes, including on dog walking and dry cleaning